Name: Chondroitin sulfate nanogel
Composition: Aminomalonic acid 1-ethyl-3- (3-dimethylamino-propyl) carbon diimine hydrochloride CS
Particle size: 152 ± 7.27 nm, 131 ± 8.23 nm
Application: Cancer cell-specific delivery for CDDP
Storage conditions: -4℃
Other instructions: shelf life of half a year under sealed state [Main advantages] The release rate of CDDP in CS-nanogels is controlled by simple incorporation of PEG-PAEU hydrogel precursors, thus forming a microporous network of nanogel incorporation and being converted into nanogels at lower pH and temperatures. Cancer cell-specific targeting was significantly improved compared to normal cells. CS-nanogels containing both hydrogel precursors can form an in situ gel and are bioresorbable within 8 weeks after subcutaneous administration without causing significant inflammation.
Title:
Injectable hydrogels-incorporating cancer cell-specific cisplatin releasing
nanogels for targeted drug delivery
Article link:https://sci-hub.se/10.1039/c7tb00873b
Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance |
Message
|
|
Scan code concerns WeChat official account
QQCommunication group:1092348845
|
|
Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance.The website pictures are from the Internet. The pictures are for reference only. Please take the real object as the standard. In case of infringement, please contact us to delete them immediately. |